Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 5 of 59, showing 10 Applications out of 584 total, starting on record 41, ending on 50

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

41.

ECCT/25/07/06   SASI
    Randomized Controlled Trial of Surfactant Administered via Supraglottic Airway Device (SALSA) Compared to Endotracheal Tube (InSurE) on Survival without Mechanical Ventilation in Preterm Neonates with Respiratory Distress Syndrome in Sub-Saharan Africa   
Principal Investigator(s)
1. Mary Waiyego Kariuki
Site(s) in Kenya
Kenyatta national Hospital
 
31-10-2025 View

42.

ECCT/25/07/05   Cabotegravir + Rilpivirine Lon
    A Phase 4, Open-Label, Rollover Study to Provide Continued Access to Cabotegravir Long-acting Injection and Rilpivirine Long-acting Injection to Participants Living with Human Immunodeficiency Virus Type 1 (HIV-1) Infection Who Participated in Longacting Combination Therapy Studie   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Aga Khan University Hospital (Nairobi City county)
2. Moi University Clinical Research Centre (Elgeyo/Marakwet county)
3. KEMRI-WRP (Kericho county)
4. University of Nairobi - Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
31-10-2025 View

43.

ECCT/25/07/04   PROPS Trial
    Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial   (Probiotics in preterm and small for gestational age infants, PROPS trial)   
Principal Investigator(s)
1. Mourine Ikol
Site(s) in Kenya
1. Kisii Teaching and Referral Hospital (Kisii county)
2. Homabay County Referral Hospital (Homa Bay county)
3. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
4. Migori County Referral Hospital (Migori county)
 
20-04-2026 View

44.

ECCT/25/07/03   PROPS Trial
    Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial   
Principal Investigator(s)
1. Joyce Akuka
Site(s) in Kenya
1. Migori County Referral Hospital (Migori county)
2. Homabay County Referral Hospital (Homa Bay county)
3. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
4. Kisii Teaching and Referral Hospital (Kisii county)
 
14-04-2026 View

45.

ECCT/25/07/02   PROPS Trial
    Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial   (Probiotics in preterm and small for gestational age infants, PROPS trial)   
Principal Investigator(s)
1. Meshack Liru
Site(s) in Kenya
1. Homabay County Referral Hospital (Homa Bay county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
3. Kisii Teaching and Referral Hospital (Kisii county)
4. Migori County Referral Hospital (Migori county)
 
14-04-2026 View

46.

ECCT/25/07/01   FIH Study of CLY-124
    A Phase 1, Randomized, Placebo-Controlled, Double Blind, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CLY-124 in Healthy Volunteers and Participants with Sickle Cell Disease   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. Strathmore University Medical Center [SUMC], Creates for Research in Therapeutic Sciences (Nairobi City county)
2. Victoria Biomedical Research Institute [VIBRI] (Kisumu county)
 
18-12-2025 View

47.

ECCT/25/06/03   ZHR-001
    Physiological and Biomarker Monitoring: Enhancing Vital Signs and Biomarkers Algorithm of Binah.AI in the Kenyan Population   
Principal Investigator(s)
1. Borna Achieng Nyaoke
Site(s) in Kenya
Zuri Health Medical Centre
 
21-11-2025 View

48.

ECCT/25/06/02   Neosep1
    An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase.   
Principal Investigator(s)
1. Nayirat Mohamed Dormohamed
Site(s) in Kenya
1. Coast General Teaching and Referral Hospital (Mombasa county)
 
02-10-2025 View

49.

ECCT/25/06/01   Neosep1
    An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase.   
Principal Investigator(s)
1. Christine Nafula Manyasi
Site(s) in Kenya
1. Mbagathi County Referral Hospital (Nairobi City county)
 
02-10-2025 View

50.

ECCT/25/05/13   IVI CCV 002
    A Phase II, randomized, controlled, age-descending study in adults and children to evaluate the safety and immunogenicity of the OSP:rTTHc Cholera Conjugate Vaccine in cholera-endemic region   
Principal Investigator(s)
1. Walter Jaoko
Site(s) in Kenya
KAVI - Institute of Clinical Research, University of Nairobi
 
07-10-2025 View